◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Almadex Minerals Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 131,105 0.00 47,688 0.00 0.00 --
Operating Revenue 131,105 0.00 47,688 0.00 0.00 --
Cost Of Revenue 103,294 31,874 30,803 38,482 38,999 --
Gross Profit 27,811 -31,874 16,885 -38,482 -38,999 --
Selling General And Administration 608,473 406,019 379,699 396,823 340,560 --
General And Administrative Expense 523,260 375,544 319,430 367,908 339,226 --
Other Operating Expenses 63,479 118,132 154,094 179,875 98,049 --
Operating Expense 671,952 524,151 533,793 576,698 438,609 --
Operating Income -644,141 -556,025 -516,908 -615,180 -477,608 --
EBIT -644,141 -556,025 -516,908 -615,180 -477,608 --
Interest Income 111,077 96,043 80,243 206,426 202,034 --
Interest Income Non Operating 111,077 96,043 80,243 206,426 202,034 --
Net Interest Income 111,077 132,103 158,445 198,113 306,444 --
Other Income Expense 1.7M -1.2M 984,877 1.5M 590,928 --
Other Non Operating Income Expenses 28,417 -76,138 1.2M -71,833 695,281 --
Special Income Charges -35,345 -30,178 -13,087 345,576 331,512 --
Gain On Sale Of Security 1.8M -1.1M -163,057 1.3M -435,865 --
Earnings From Equity Interest -16,897 -37,962 -8,369 -- 0.00 0.00
Pretax Income 1.2M -1.6M 626,414 1.1M 419,764 --
Tax Provision -181,373 -- -- 20,009 -201,383 --
Tax Effect Of Unusual Items 259,403 0.00 -26,422 28,928 -15,653 --
Net Income From Continuing And Discontinued Operation 1.4M -1.6M 626,414 1.1M 621,147 --
Net Income From Continuing Operation Net Minority Interest 1.4M -1.6M 626,414 1.1M 621,147 --
Net Income Including Noncontrolling Interests 1.4M -1.6M 626,414 1.1M 621,147 --
Net Income Common Stockholders 1.4M -1.6M 626,414 1.1M 621,147 --
Net Income 1.4M -1.6M 626,414 1.1M 621,147 --
EBITDA -614,876 -524,151 -486,105 -576,698 -438,609 --
Normalized EBITDA -2.3M 583,860 -309,961 -2.2M -334,256 --
Reconciled Depreciation 29,265 31,874 30,803 38,482 38,999 --
Basic EPS 0.02 -0.03 0.01 -- 0.01 0.00
Diluted EPS 0.02 -0.03 0.01 -- 0.01 0.00
Basic Average Shares 61.0M 61.0M 61.0M -- 61.0M 61.0M
Diluted Average Shares 61.6M 61.0M 61.0M -- 61.0M 61.0M
Total Unusual Items 1.7M -1.1M -176,144 1.6M -104,353 --
Total Unusual Items Excluding Goodwill 1.7M -1.1M -176,144 1.6M -104,353 --
Tax Rate For Calcs 0.15 0.00 0.15 0.02 0.15 --
Normalized Income -80,768 -538,022 776,136 -489,425 709,847 --
Diluted NI Availto Com Stockholders 1.4M -1.6M 626,414 1.1M 621,147 --
Gain On Sale Of Ppe -10,252 0.00 -511.00 -6,814 407,924 --
Impairment Of Capital Assets 25,093 30,178 12,576 20,551 76,412 --
Net Income Continuous Operations 1.4M -1.6M 626,414 1.1M 621,147 --
Net Non Operating Interest Income Expense 111,077 132,103 158,445 198,113 306,444 --
Other Gand A 347,057 342,744 319,430 367,908 337,476 --
Reconciled Cost Of Revenue 103,294 31,874 30,803 38,482 38,999 --
Salaries And Wages 176,203 32,800 -- 0.00 1,750 0.00
Selling And Marketing Expense 85,213 30,475 60,269 28,915 1,334 --
Total Expenses 775,246 556,025 564,596 615,180 477,608 --
Total Other Finance Cost -- -36,060 -78,202 8,313 -104,410 -102,070
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 8.6M 10.3M 12.2M 12.9M 13.2M --
Cash Cash Equivalents And Short Term Investments 19.9M 11.1M 13.1M 13.9M 14.4M --
Cash Equivalents -- -- 10.5M -- 11.5M 12.3M
Cash Financial -- -- 1.7M -- 1.8M 2.6M
Other Short Term Investments 11.3M 857,835 872,356 1.0M 1.1M --
Accounts Receivable 166,637 49,309 29,224 160,818 111,968 --
Receivables 166,637 49,309 29,224 160,818 111,968 --
Prepaid Assets 155,777 111,265 40,315 72,636 72,728 --
Current Assets 20.3M 11.3M 13.2M 14.2M 14.5M --
Gross PPE 8.9M 7.6M 6.8M 6.5M 6.0M --
Accumulated Depreciation -1.1M -1.2M -1.1M -1.1M -1.2M --
Net PPE 7.8M 6.4M 5.7M 5.4M 4.8M --
Investments And Advances 156,489 173,386 211,348 219,717 -- --
Long Term Equity Investment 156,489 173,386 211,348 219,717 -- --
Other Non Current Assets 150,736 146,978 148,467 139,223 131,978 --
Total Non Current Assets 8.2M 15.8M 15.6M 14.0M 12.5M --
Total Assets 28.5M 27.1M 28.8M 28.2M 27.0M --
Accounts Payable 321,791 253,653 356,567 395,422 241,316 --
Payables 321,791 253,653 356,567 395,422 339,995 --
Payables And Accrued Expenses 321,791 253,653 356,567 395,422 339,995 --
Current Liabilities 321,791 253,653 356,567 395,422 339,995 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 321,791 253,653 356,567 395,422 339,995 --
Common Stock 23.6M 23.6M 23.6M 23.6M 23.6M --
Capital Stock 23.6M 23.6M 23.6M 23.6M 23.6M --
Retained Earnings 2.1M 750,846 2.4M 1.8M 672,467 --
Common Stock Equity 28.2M 26.8M 28.4M 27.8M 26.7M --
Stockholders Equity 28.2M 26.8M 28.4M 27.8M 26.7M --
Total Equity Gross Minority Interest 28.2M 26.8M 28.4M 27.8M 26.7M --
Total Capitalization 28.2M 26.8M 28.4M 27.8M 26.7M --
Net Tangible Assets 28.2M 26.8M 28.4M 27.8M 26.7M --
Tangible Book Value 28.2M 26.8M 28.4M 27.8M 26.7M --
Working Capital 19.9M 11.0M 12.8M 13.8M 14.2M --
Invested Capital 28.2M 26.8M 28.4M 27.8M 26.7M --
Share Issued 61.2M 61.0M 61.0M 61.0M 61.0M --
Ordinary Shares Number 61.2M 61.0M 61.0M 61.0M 61.0M --
Dueto Related Parties Current -- -- -- -- 98,679 --
Investmentsin Associatesat Cost 156,489 173,386 211,348 219,717 -- --
Machinery Furniture Equipment 358,438 422,811 422,811 473,826 559,049 --
Non Current Deferred Assets 160,266 160,266 160,266 160,266 180,275 --
Non Current Deferred Taxes Assets 160,266 160,266 160,266 160,266 180,275 --
Non Current Note Receivables 0.00 8.9M 9.4M 8.1M 7.3M --
Other Equity Interest 2.5M 2.5M 2.5M 2.5M 2.5M --
Other Properties 137,473 137,473 137,473 137,473 100,877 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -194,104 -1.1M -342,901 468,645 -296,326 --
Cash Flow From Continuing Operating Activities -194,104 -1.1M -342,901 468,645 -296,326 --
Depreciation And Amortization 29,265 31,874 30,803 38,482 38,999 --
Depreciation Amortization Depletion 29,265 31,874 30,803 38,482 38,999 --
Stock Based Compensation 7,500 32,800 -- 0.00 1,750 0.00
Change In Working Capital -67,565 -148,813 66,514 266,722 -86,267 --
Changes In Account Receivables -161,840 -91,035 163,915 126,178 -18,398 --
Change In Receivables -161,840 -91,035 163,915 126,178 -18,398 --
Change In Payables And Accrued Expense 94,275 -57,778 -97,401 140,544 -67,869 --
Change In Payable 94,275 -57,778 -97,401 140,544 -67,869 --
Other Non Cash Items -28,417 40,078 -1.2M -292,795 -799,691 --
Capital Expenditure -- -- -25,712 -57,807 -1.3M -50,399
Purchase Of PPE 0.00 0.00 -25,712 -57,807 0.00 --
Net PPE Purchase And Sale 14,464 0.00 -4,818 -5,185 677.00 --
Investing Cash Flow -1.4M -837,493 -308,015 -822,067 -1.3M --
Cash Flow From Continuing Investing Activities -1.4M -837,493 -308,015 -822,067 -1.3M --
Financing Cash Flow -40,791 0.00 0.00 0.00 0.00 --
Cash Flow From Continuing Financing Activities -40,791 -- -- 0.00 0.00 0.00
Changes In Cash -1.7M -2.0M -650,916 -353,422 -1.6M --
Beginning Cash Position 10.3M 12.2M 12.9M 13.2M 14.9M --
End Cash Position 8.6M 10.3M 12.2M 12.9M 13.2M --
Free Cash Flow -194,104 -1.1M -368,613 410,838 -296,326 --
Asset Impairment Charge 25,093 30,178 12,576 20,551 76,412 --
Depreciation 29,265 31,874 30,803 38,482 38,999 --
Earnings Losses From Equity Investments 16,897 37,962 8,369 -- 0.00 0.00
Gain Loss On Sale Of PPE 10,252 0.00 511.00 6,814 -407,924 --
Net Foreign Currency Exchange Gain Loss -71,447 484,281 -10,031 -490,683 91,058 --
Net Income From Continuing Operations 1.4M -1.6M 626,414 1.1M 621,147 --
Net Other Financing Charges -40,791 -- -- -- -- --
Net Other Investing Changes -1.4M -837,493 -303,197 -661,721 -1.3M --
Operating Gains Losses -44,298 522,243 -1,151 -474,425 -316,866 --
Sale Of PPE 14,464 0.00 20,894 52,622 677.00 --
Unrealized Gain Loss On Investment Securities -1.5M 14,521 169,535 -6,514 168,190 --
NEWS
Loading news...
TRENDING
Loading...